In addition to traditional methods for identifying prostate cancer, the CHI St. Joseph Health urology team now also uses the UroNav Fusion Biopsy System, an MR/ultrasound-guided biopsy that’s considered the new standard in prostate care.
Patients who may benefit from MR/ultrasound-guided biopsy include:
Fusing the benefits of pre-biopsy MR images with ultrasound-guided biopsy to create a real-time visualization for our urologists, this method supports early diagnosis of prostate cancer and helps identify areas in the gland that may need closer evaluation. It has also been shown to target areas that may be missed on a standard biopsy and potentially decreases un-needed biopsies.
According to the American Cancer Society, prostate cancer is the most common cancer, affecting 1 in 9 men. CHI St. Joseph Health urologists are committed to providing leading-edge diagnostic resources and supporting your long-term prostate health.
To schedule an appointment or for more information, please call 979.774.3041.